Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks
This article is from
The Cancer Letter
archive.
Vol. 37 No. 7 | July 25, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
NCI Buys Building For PDQ, ICRDB With Donated Money
December 10, 1982
TCL Archive
Vermont Cancer Center’s NCI Core Grant Renewed.
May 11, 2001
TCL Archive
In Brief
February 7, 2014
TCL Archive
Also M.D. Anderson awarded three new, one renewal SPORE grant.
October 31, 2003
TCL Archive
FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine
June 16, 1989
TCL Archive
Gene Variant Associated With 44 Percent Cancer Risk Reduction
October 26, 2012